AstraZeneca Settles Dispute Over Prilosec OTC

Law360, New York (November 1, 2007, 12:00 AM EDT) -- Generic drugmaker Dexcel Pharma Technologies Ltd. has reached a settlement with AstraZeneca in a patent dispute over Prilosec OTC, Dexcel partner Perrigo Co. revealed Thursday.

The new agreement paves the way for over-the-counter pharmaceutical company Perrigo to become the exclusive U.S. distributor of store-brand Prilosec OTC, developed and made by Dexcel.

Under the agreement, Dexcel and Perrigo will be able to sell a store-brand version of the popular heartburn medication as soon as the U.S. Food and Drug Administration issues its final regulatory approval. Perrigo estimates...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.